TRI-LUMA (Galderma Laboratories, L.P.)
Welcome to the PulseAid listing for the TRI-LUMA drug offered from Galderma Laboratories, L.P.. This Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA],Depigmenting Activity [PE],Melanin Synthesis Inhibitor [EPC],Melanin Synthesis Inhibitors [MoA],Retinoid [EPC],Retinoids [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Galderma Laboratories, L.P. |
| NON-PROPRIETARY NAME: | fluocinolone acetonide, hydroquinone, and tretinoin |
| SUBSTANCE NAME: | FLUOCINOLONE ACETONIDE; HYDROQUINONE; TRETINOIN |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA],Depigmenting Activity [PE],Melanin Synthesis Inhibitor [EPC],Melanin Synthesis Inhibitors [MoA],Retinoid [EPC],Retinoids [Chemical/Ingredient] |
| ROUTE: | TOPICAL |
| DOSAGE FORM: | CREAM |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2002-01-18 |
| END MARKETING DATE: | 0000-00-00 |
TRI-LUMA HUMAN PRESCRIPTION DRUG Details:
| Item Description | TRI-LUMA from Galderma Laboratories, L.P. |
| LABELER NAME: | Galderma Laboratories, L.P. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | .1; 40; .5(mg/g; mg/g; mg/g) |
| START MARKETING DATE: | 2002-01-18 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0299-5950_a3841975-609a-af4d-e8ca-e5880cfc7929 |
| PRODUCT NDC: | 0299-5950 |
| APPLICATION NUMBER: | NDA021112 |
Other FLUOCINOLONE ACETONIDE; HYDROQUINONE; TRETINOIN Pharmaceutical Manufacturers / Labelers:
